Position in LKFT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$61,259,453
+$14,759,453 QoQ
Shares Held
2,043,344
+31.8% QoQ
Ownership
3.12%
of shares outstanding
% of Portfolio
10.56%
of 13F equity value
Holder Rank
#4
of 78 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LKFT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Prosight Management, LP holds $415,390,745 across 22 Biotechnology names. LKFT ranks #1 (14.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LKFT |
Lakefront Biotherapeutics NV
This page
|
2,043,344 | $61,259,453 | |
| 2 | JANX |
Janux Therapeutics, Inc.
|
3,804,481 | $58,436,828 | |
| 3 | NKTR |
Nektar Therapeutics
|
810,000 | $56,546,100 | |
| 4 | STTK |
Shattuck Labs, Inc.
|
5,957,877 | $41,347,666 | |
| 5 | INSM |
INSMED Inc
|
375,609 | $40,047,431 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
98,080 | $29,525,022 | |
| 7 | SNDX |
Syndax Pharmaceuticals Inc
|
1,200,000 | $26,232,000 | |
| 8 | KURA |
Kura Oncology, Inc.
|
2,021,964 | $22,180,945 |
All Filings in LKFT
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $61,259,453 | 2,043,344 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $46,500,000 | 1,550,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $35,123,462 | 1,074,112 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $39,836,000 | 1,150,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $49,644,435 | 1,773,649 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $33,030,237 | 1,314,898 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $28,187,500 | 1,025,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $29,620,389 | 1,028,843 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $33,452,504 | 1,349,980 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $29,994,686 | 931,512 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $33,629,501 | 827,294 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $25,228,651 | 730,207 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $16,975,550 | 417,500 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $14,509,320 | 375,500 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $20,636,700 | 465,000 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $17,269,200 | 405,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $20,590,200 | 369,000 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $23,195,480 | 374,000 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $19,069,467 | 345,900 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $13,188,274 | 250,680 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $4,960,080 | 72,000 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $5,120,240 | 66,419 | Shares | Sole | 2021-05-14 | |
| No filing history on record for this holder in this stock. | ||||||